Ara-290

Non-erythropoietic EPO-derived peptide. Neuropathy trials used daily SubQ for 28 days.

What it does / how it works

A small EPO-derived peptide built to hit the innate repair receptor without making more red cells. Neuropathy trials used daily SubQ for 28 days.

Class Innate repair receptor peptide
Typical vial 10 mg
Reconstitution 1–2 mL BAC per 10 mg
Storage after mix 2–8°C, use within 28 days

Protocol

Goal Dose How often How long Route
Days 1-28 4 mg Once daily 28 days SubQ
Then off None Stop Reassess after the 28-day block –

Watch: A 10 mg vial is 2–5 days at trial-style doses.

Ara-290 FAQ — Australia

Ara-290 was designed to activate the innate repair receptor without stimulating erythropoiesis. Small trials in sarcoidosis small-fiber neuropathy used daily SQ dosing for 28 days.

Recommended Supplier — Ara-290 Australia

Our products offer premium-grade research materials with independent testing at a leading Australian university. Every batch is strictly verified by RP-HPLC and LC-MS. For research purposes only.

Related Research — Australia

Explore similar research-grade peptides, selected to complement your research needs.

Tesamorelin + Ipamorelin

Tesamorelin target is 1-2 mg daily. Ipamorelin target....

Super Human Blend

One serving: L-Arginine 110 mg, L-Ornithine 110 mg,....

Semax + Selank

Short course. Intranasal preferred. Then 2-4 weeks off.....

Retatrutide + Cagrilintide

5+5 mg is a late stock, not a....
Select your currency
AUD Australian dollar